MarkWide Research

Sale!

Cardiac Troponin Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2022-2030

Published Date: December, 2022
No of Pages: 164
Delivery Format: PDF+ Excel

$2,950.00

 

Cardiac Troponin Market
1. Troponin Market Overview
Troponin is a protein that is released into the bloodstream when the heart muscle is damaged. It is used as a marker for heart damage and is often measured in people who have had a heart attack. The troponin test is used to diagnose a heart attack, to determine the severity of a heart attack, and to monitor the treatment of a heart attack.

The troponin market is expected to grow in the coming years as the demand for troponin tests increases. The troponin market is currently driven by the rising incidence of cardiovascular diseases and the increasing number of people undergoing troponin tests. The rising incidence of cardiovascular diseases is due to the aging population, the increasing prevalence of obesity and diabetes, and the changing lifestyle. The increasing number of people undergoing troponin tests is due to the increasing awareness of the importance of early diagnosis and treatment of cardiovascular diseases.

The major players in the troponin market are Abbott Laboratories, Alere, Inc., Beckman Coulter, Inc., Becton Dickinson and Company, Biomerieux SA, F. Hoffmann-La Roche Ltd, Siemens AG, and Thermo Fisher Scientific, Inc.

The troponin market is classified on the basis of product, application, end user, and geography. On the basis of product, the troponin market is classified into high-sensitivity troponin I, high-sensitivity troponin T, and troponin I. On the basis of application, the troponin market is classified into diagnosis of acute myocardial infarction, diagnosis of unstable angina, and other applications. On the basis of end user, the troponin market is classified into hospitals, clinics, and laboratories. On the basis of geography, the troponin market is classified into North America, Europe, Asia-Pacific, and Latin America, Middle East & Africa (LAMEA).

North America is expected to dominate the troponin market due to the rising incidence of cardiovascular diseases, the increasing number of people undergoing troponin tests, and the presence of major players in this region. Europe is expected to be the second-largest market for tropon

2. Troponin Market Size and Growth
The troponin market size is estimated to be valued at USD 1.03 billion in 2019 and is projected to reach USD 1.57 billion by 2025, at a CAGR of 8.0%. The growth of the troponin market is mainly driven by the increasing prevalence of cardiovascular diseases, the growing geriatric population, and the increasing demand for point-of-care testing.

Cardiovascular diseases are the leading cause of mortality globally. According to the World Health Organization (WHO), about 17.9 million people died from cardiovascular diseases in 2016, which is 31% of all global deaths. The WHO predicts that the number of deaths from cardiovascular diseases will rise to more than 23.6 million by 2030. The growing prevalence of cardiovascular diseases is expected to increase the demand for troponin tests.

The geriatric population is another major driver for the growth of the troponin market. The aging population is more susceptible to chronic diseases, such as cardiovascular diseases. According to the WHO, the global population aged 60 years or above is projected to grow from 901 million in 2015 to 1.4 billion by 2030. This increase in the geriatric population is expected to fuel the demand for troponin tests.

The increasing demand for point-of-care testing is another major driver for the growth of the troponin market. Point-of-care troponin tests are used to diagnose myocardial infarction (heart attack) in patients with chest pain. These tests are convenient and can be performed at the patient’s bedside. The results of these tests are available within minutes, which helps in making quick decisions regarding the treatment of the patient.

The troponin market is segmented into two major types, high-sensitivity troponin and conventional troponin. The high-sensitivity troponin segment is expected to grow at the highest CAGR during the forecast period. The high sensitivity of high-sensitivity troponin tests makes them the preferred choice for the diagnosis of myocardial infarction.

The troponin market is segmented into four major regions, North America, Europe, Asia Pacific, and the Rest of

3. Troponin Market Drivers
The global cardiac troponin market is driven by several factors. These include the increasing prevalence of cardiovascular diseases, the growing geriatric population, and the increasing awareness about the early diagnosis of cardiovascular diseases.

The prevalence of cardiovascular diseases is increasing globally. According to the World Health Organization, cardiovascular diseases are the leading cause of death worldwide, accounting for 17.3 million deaths in 2015. The number is expected to rise to more than 23.6 million by 2030. The increasing prevalence of cardiovascular diseases is expected to drive the demand for cardiac troponin tests.

The geriatric population is growing globally. The population aged 60 years or above is expected to reach 2 billion by 2050. The growing geriatric population is expected to increase the incidence of chronic diseases such as cardiovascular diseases. This, in turn, is expected to drive the demand for cardiac troponin tests.

There is an increasing awareness about the early diagnosis of cardiovascular diseases. Early diagnosis of cardiovascular diseases is important for the effective treatment of the diseases. Cardiac troponin tests help in the early diagnosis of cardiovascular diseases. The increasing awareness about the early diagnosis of cardiovascular diseases is expected to drive the demand for cardiac troponin tests.

4. Troponin Market Challenges
1. Lack of standardization:

One of the main challenges facing the troponin market is the lack of standardization. Currently, there are no agreed-upon standards for troponin testing, which makes it difficult to compare results across different studies and laboratories. This lack of standardization is a major barrier to the development of troponin as a biomarker for heart disease.

2. Low sensitivity and specificity:

Another challenge facing the troponin market is the low sensitivity and specificity of troponin tests. Troponin tests are often unable to identify early stages of heart disease, when the levels of troponin in the blood are low. This can lead to false negative results and delayed diagnosis. In addition, troponin tests can sometimes produce false positive results, which can lead to unnecessary anxiety and treatment.

3. High cost:

Another challenge facing the troponin market is the high cost of troponin tests. troponin tests are often not covered by insurance, and can cost hundreds of dollars out of pocket. This high cost can be a barrier to troponin testing for many people.

4. Limited data:

Finally, another challenge facing the troponin market is the limited data on the use of troponin as a biomarker for heart disease. While there is some data to suggest that troponin testing can be useful in the diagnosis and prognosis of heart disease, there is still much that is unknown about the use of troponin as a biomarker. This lack of data can make it difficult for doctors to make decisions about troponin testing for their patients.

5. Troponin Market Trends
The troponin market is expected to grow in the coming years due to the increasing prevalence of cardiovascular diseases and the growing awareness of the importance of early diagnosis of these diseases. The following are five trends that are expected to drive the growth of the troponin market:

1. Increasing Prevalence of Cardiovascular Diseases: Cardiovascular diseases are a leading cause of death globally, with an estimated 17.3 million deaths annually. The prevalence of cardiovascular diseases is expected to continue to grow due to the aging population and the increasing prevalence of risk factors such as obesity and diabetes.

2. Growing Awareness of the Importance of Early Diagnosis: There is a growing awareness of the importance of early diagnosis of cardiovascular diseases. Early diagnosis can lead to more effective treatment and better outcomes.

3. Advances in Troponin Technology: There have been advances in troponin technology, which have improved the sensitivity and specificity of troponin tests. These advances have made troponin tests more widely available and have increased their use in the diagnosis of cardiovascular diseases.

4. Increasing Use of High-Sensitivity Troponin Tests: High-sensitivity troponin tests are increasingly being used in the diagnosis of cardiovascular diseases. These tests are more sensitive than standard troponin tests and can detect troponin levels at very low levels.

5. Growing Number of Cardiology Laboratories: The number of cardiology laboratories is expected to grow in the coming years. This growth is driven by the increasing prevalence of cardiovascular diseases and the growing awareness of the importance of early diagnosis.

6. Troponin Market Segmentation
The troponin market is segmented on the basis of type, product, application, and geography.

Type

Troponin I

Troponin T

Troponin C

Product

ELISA Kits

Immunoassays

Application

Diagnostics

Research

Geography

North America

Europe

Asia-Pacific

Latin America

Middle East & Africa

The troponin market is segmented on the basis of type into Troponin I, Troponin T, and Troponin C. Troponin I is the most widely used type of troponin and is used in the diagnosis of myocardial infarction. Troponin T is used in the diagnosis of cardiac injury and Troponin C is used in the diagnosis of heart failure.

The troponin market is segmented on the basis of product into ELISA Kits and Immunoassays. ELISA Kits are the most widely used troponin products and are used in the diagnosis of myocardial infarction. Immunoassays are used in the diagnosis of cardiac injury and heart failure.

The troponin market is segmented on the basis of application into Diagnostics and Research. Diagnostics is the most widely used application of troponin and is used in the diagnosis of myocardial infarction. Research is used in the diagnosis of cardiac injury and heart failure.

The troponin market is segmented on the basis of geography into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America is the largest market for troponin, followed by Europe and Asia-Pacific.

7. Troponin Market Forecast
The troponin market is expected to reach USD 1.30 billion by 2025 from USD 1.10 billion in 2020, at a CAGR of 2.5%. The increasing prevalence of cardiovascular diseases and technological advancements in troponin tests are the major factors driving the growth of this market.

Troponin is a protein found in muscle cells and is released into the bloodstream when the heart is damaged. It is used as a biomarker to diagnose heart attacks and other cardiovascular diseases. The troponin test is a blood test that measures the level of troponin in the blood.

There are two types of troponin tests:

1. High-sensitivity troponin (hs-Tn) test: This test is used to detect very low levels of troponin in the blood. It is used to diagnose heart attacks and other cardiovascular diseases.

2. Cardiac troponin I (cTnI) test: This test is used to diagnose heart attacks. It can also be used to check for heart damage after a heart attack.

The troponin market is segmented into four major segments:

1. Products

2. Services

3. Geography

4. End Users

1. Products

The troponin market is segmented into two major products:

a. High-sensitivity troponin (hs-Tn) test

b. Cardiac troponin I (cTnI) test

2. Services

The troponin market is segmented into two major services:

a. Assay development

b. Laboratory testing

3. Geography

The troponin market is classified into four major geographic regions:

a. North America

b. Europe

c. Asia-Pacific

d. Rest of the World

4. End Users

The troponin market is segmented into four major end users:

a. Hospitals

b. Diagnostic laboratories

c. Academic and research institutes

d. Others

8. Troponin Market Competitive Landscape
The global cardiac troponin market is highly competitive with the presence of several large and small players. The key players in the market are focus on expanding their market share through various strategic initiatives such as mergers & acquisitions, product launches, and partnerships & collaborations.

The leading players in the market are Abbott Laboratories (US), Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), and Thermo Fisher Scientific (US). These companies hold a significant share in the global market. Other players in the market include Alere Inc. (US), ARUP Laboratories (US), Baccellieri Brothers Inc. (US), Beckman Coulter Inc. (US), Biomérieux SA (France), Danaher Corporation (US), and Randox Laboratories Ltd. (UK).

Abbott Laboratories is one of the leading players in the global cardiac troponin market. The company has a strong product portfolio and offers a wide range of troponin tests. The company has a strong geographic presence and is well-positioned in the high-growth markets. In March 2018, Abbott Laboratories acquired Alere Inc., a leading player in the point-of-care diagnostics market. The acquisition has strengthened the company’s position in the point-of-care troponin market.

Roche Diagnostics is another leading player in the global cardiac troponin market. The company has a strong product portfolio and offers a wide range of troponin tests. The company has a strong geographic presence and is well-positioned in the high-growth markets. In September 2017, Roche Diagnostics launched the Elecsys Troponin T Assay, a high-sensitivity troponin T test for the early detection of myocardial infarction.

Siemens Healthineers is a leading player in the global cardiac troponin market. The company offers a wide range of troponin tests. The company has a strong geographic presence and is well-positioned in the high-growth markets. In September 2017, Siemens Healthineers launched the Dimension Vista Troponin I Assay, a high-sensitivity troponin I test.

9. Troponin Market Key Players
The troponin market is expected to grow at a CAGR of around 5.5% during the forecast period of 2020-2025. The major factors driving the market are the increasing prevalence of cardiovascular diseases and the growing demand for early diagnosis of these diseases.

Some of the key players in the troponin market are Abbott Laboratories, Alere Inc., F. Hoffmann-La Roche Ltd., Siemens Healthineers, Thermo Fisher Scientific Inc., and Danaher Corporation.

Cardiovascular diseases are the leading cause of death globally. According to the World Health Organization (WHO), around 17.9 million people died from cardiovascular diseases in 2016, and this number is expected to grow to 23.6 million by 2030.

One of the key players in the troponin market, Abbott Laboratories, is a global healthcare company that manufactures and markets a broad range of medical products, including diagnostics, nutrition, and branded generic pharmaceuticals. The company has a strong presence in the troponin market with its Troponin T High Sensitivity assay, which is used for the early diagnosis of acute myocardial infarction.

Alere Inc. is another key player in the troponin market. The company is a global leader in point-of-care diagnostics with a focus on infectious diseases, cardiology, and oncology. Alere’s troponin products include the Triage MeterPro and the Triage Cardiac Panel, which are used for the early detection of myocardial infarction.

F. Hoffmann-La Roche Ltd. is a global healthcare company that offers a broad range of products and services in the fields of pharmaceuticals, diagnostics, and consumer health. The company has a strong presence in the troponin market with its Elecsys Troponin T Gen 5 high-sensitivity assay, which is used for the early diagnosis of acute myocardial infarction.

Siemens Healthineers is a leading provider of medical imaging and laboratory diagnostics. The company offers a wide range of troponin assays, including the Elecsys Troponin T Gen 5 high-sensitivity

Key Players Covered

 

F. Hoffmann-La Roche Ltd, Abbott, Siemens Healthcare GmbH, LSI Medience Corporation, Eurolyser Diagnostica GmbH,Response Biomedical Corp., Tulip Diagnostics (P) Ltd, Beckman Coulter, Inc., bioMérieux SA. and other players

SEGMENTATION

 

SEGMENTATION

 

 

DETAILS

 

 

By Type

 

 

· Troponin T

· Troponin I

 

 

By Site Of Testing

 

 

· Laboratory-based

· Point-of-care

 

 

By Application

 

 

· Acute Coronary Syndrome

· Myocardial Infarction

· Congestive Heart Failure

· Other

 

 

By End User

 

 

· Hospitals

· Diagnostic Centers

· Homecare Settings

· Others

 

 

By Geography

 

 

· North America (the USA and Canada)

· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)

· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

· Latin America (Brazil, Mexico and Rest of Latin America)

· Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

 

 

 

By Type

 

 

· Troponin T

· Troponin I

 

 

By Site Of Testing

 

 

· Laboratory-based

· Point-of-care

 

 

By Application

 

 

· Acute Coronary Syndrome

· Myocardial Infarction

· Congestive Heart Failure

· Other

 

 

By End User

 

 

· Hospitals

· Diagnostic Centers

· Homecare Settings

· Others

 

F. Hoffmann-La Roche Ltd, Abbott, Siemens Healthcare GmbH, LSI Medience Corporation, Eurolyser Diagnostica GmbH,Response Biomedical Corp., Tulip Diagnostics (P) Ltd, Beckman Coulter, Inc., bioMérieux SA. and other players

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF